Blepharitis epidemiology and demographics

Jump to navigation Jump to search

Blepharitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Blepharitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Blepharitis epidemiology and demographics On the Web

recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Blepharitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Blepharitis epidemiology and demographics

CDC on Blepharitis epidemiology and demographics

Blepharitis epidemiology and demographics in the news

Blogs on Blepharitis epidemiology and demographics

Directions to Hospitals Treating Blepharitis

Risk calculators and risk factors for Blepharitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Blepharitis is one of the most common ocular disorders encountered in clinical practice and affects more than 180 million people in the United States.

Epidemiology and Demographics

Prevalence

Blepharitis is one of the most common ocular disorders encountered by eye care practitioners.[1] In the United States, blepharitis is estimated to affect more than 180 million people.[2] In a United States survey of ophthalmologists and optometrists, it was estimated that 37% and 47% of the patients presented with certain form of blepharitis in clinical practice, respectively.[3]

incidence

The true incidence of blepharitis remains undetermined.

Age

Blepharitis can affect all age groups.[4][5][6] A single-center study of patients with chronic blepharitis reported a mean age of 50 years.[7] Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are relatively young, with a mean age of 42 years.[8]

Gender

Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are mostly female.[9]

Race

Blepharitis can affect all ethnic groups.[10][11][12] There is no racial predilection for blepharitis.

References

  1. Macsai MS (2008). "The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)". Trans Am Ophthalmol Soc. 106: 336–56. PMC 2646454. PMID 19277245.
  2. Guttman, C. (2009). Recent surveys draw attention to blepharitis. Ophthalmology Times, 34(15), 30-31.
  3. Lemp MA, Nichols KK (2009). "Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment". Ocul Surf. 7 (2 Suppl): S1–S14. PMID 19383269.
  4. Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.
  5. Pflugfelder SC, Karpecki PM, Perez VL. Treatment of blepharitis: recent clinical trials. Ocul Surf. 2014;12(4):273-84.
  6. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocular Surface 2009;7(Suppl 2):S1–14.
  7. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982;89:1173-80.
  8. McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics 1985;25(1):159–72.
  9. McCulley JP, Dougherty JM. Blepharitis associated with acne rosacea and seborrheic dermatitis. International Ophthalmology Clinics 1985;25(1):159–72.
  10. Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.
  11. Pflugfelder SC, Karpecki PM, Perez VL. Treatment of blepharitis: recent clinical trials. Ocul Surf. 2014;12(4):273-84.
  12. Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocular Surface 2009;7(Suppl 2):S1–14.